Perfil
Thomas Tillett is the founder of MBF Therapeutics, Inc. where he holds the titles of President, Chief Executive Officer & Director starting in 2008.
Mr. Tillett is also the founder of Rheogene, Inc. Currently, Mr. Tillett is the Executive Director at Sustained Acts, Inc. and Head-BioIndustrial Liaison Committee at American Society of Gene Therapy.
Previously, Mr. Tillett was the Head-Sales & Marketing at Rohm & Haas Co. and the President at Quadrant Biosystems, Inc.
Cargos activos de Thomas Tillett
| Empresas | Cargo | Inicio |
|---|---|---|
MBF Therapeutics, Inc.
MBF Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunotherapeutic animal health company that develops next generation gene based immunotherapies to treat cancer and infectious diseases | Fundador | 01/01/2008 |
American Society of Gene Therapy | Corporate Officer/Principal | - |
Sustained Acts, Inc.
Sustained Acts, Inc. Miscellaneous Commercial ServicesCommercial Services The non-profit company is based in Ambler, PA. The organization focuses on long-term personal relationships and sustainable assistance, including support for a 128-child orphanage, educational funding, and collaboration with AIC Kijabe Hospital. Its holistic child sponsorship program provides orphaned children with daily meals, safe shelter, education, medical care, and spiritual guidance, addressing physical, mental, social, and spiritual needs. Educational support extends through secondary, trade, and higher education, and the organization also prioritizes facility maintenance and capital projects such as clean water access, infrastructure improvements, and vehicle replacement. Sustained Acts, Inc. is a Christian international non-profit organization founded in 2008 that develops and leads sustainable projects supporting vulnerable and orphaned children. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Thomas Tillett.
| Empresas | Cargo | Fin |
|---|---|---|
Quadrant Biosystems, Inc. | Presidente | - |
Rohm & Haas Co.
Rohm & Haas Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty chemicals | Ventas & Marketing | - |
Rheogene, Inc.
Rheogene, Inc. BiotechnologyHealth Technology Manufactures biological equipment | Fundador | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 6 |
|---|---|
Rohm & Haas Co.
Rohm & Haas Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty chemicals | Process Industries |
MBF Therapeutics, Inc.
MBF Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an immunotherapeutic animal health company that develops next generation gene based immunotherapies to treat cancer and infectious diseases | Health Technology |
Rheogene, Inc.
Rheogene, Inc. BiotechnologyHealth Technology Manufactures biological equipment | Health Technology |
American Society of Gene Therapy | |
Sustained Acts, Inc.
Sustained Acts, Inc. Miscellaneous Commercial ServicesCommercial Services The non-profit company is based in Ambler, PA. The organization focuses on long-term personal relationships and sustainable assistance, including support for a 128-child orphanage, educational funding, and collaboration with AIC Kijabe Hospital. Its holistic child sponsorship program provides orphaned children with daily meals, safe shelter, education, medical care, and spiritual guidance, addressing physical, mental, social, and spiritual needs. Educational support extends through secondary, trade, and higher education, and the organization also prioritizes facility maintenance and capital projects such as clean water access, infrastructure improvements, and vehicle replacement. Sustained Acts, Inc. is a Christian international non-profit organization founded in 2008 that develops and leads sustainable projects supporting vulnerable and orphaned children. | Commercial Services |
Quadrant Biosystems, Inc. |
- Bolsa de valores
- Insiders
- Thomas Tillett
















